FDA Orders New Warning on Ozempic, Zepbound and Other GLP-1s Over Rare Blindness Risk
The U.S. Food and Drug Administration announced on Monday, November 9, 2026, that manufacturers of all GLP-1 receptor...
Dr. Sameena Khan is a board-certified physician with over fifteen years of clinical practice dedicated to preventive healthcare and chronic disease management. At drsameenakhan.com, she translates complex clinical research into clear, evidence-based health guidance for patients. Dr. Khan rigorously reviews medical literature to ensure all educational resources adhere to current clinical practice guidelines.